A World Health Organization (WHO) delegation led by Dr. Winifred Ugo Onodu, WHO Technical Consultant for Measles and Rubella, has met with the Commissioner for Health, Dr. Afam Obidike seeking stronger government and community backing for the exercise.
This visit marks a boost as the state steps up preparations for a major Measles–Rubella vaccination campaign.
On the occasion, the delegation led by WHO Technical Consultant for Measles and Rubella, Dr. Winifred Ugo Onodu, raised alarm over the escalating burden of measles-rubella in Nigeria.
The revealed that the country accounts for nearly half of all reported cases in Africa.
They noted that large-scale vaccination remains the most effective defence against outbreaks.
The WHO Technical Consultant warned that without widespread community response, children will remain at high risk.
She explained that the upcoming campaign will cover children between 9 months and 14 years — the most susceptible age group.
Dr. Onodu, stressed that measles spreads rapidly through air droplets from coughing and sneezing.
She also explained that rubella though less severe, can cause irreversible damage when contracted during pregnancy.
Dr Onodu warned that Congenital Rubella Syndrome could lead to blindness, deafness, heart defects and permanent disabilities in babies.
Intensified collaboration
The delegation urged intensified collaboration with media houses, traditional and religious leaders to counter misinformation and drive community awareness.
They stressed that strong public sensitisation will determine turnout and ultimately safeguard children across the state.
Responding, Dr. Obidike reaffirmed the commitment of the Anambra State Government to ensuring a successful campaign.
He urged parents, guardians, schools, churches, and community leaders to mobilise all eligible children for vaccination.
According to him, the vaccine is safe, free, WHO-approved and NAFDAC-certified.
He said it will be administered at public health facilities as well as temporary vaccination centres across the state.
Dr Obidike said health workers have been trained for seamless implementation and prompt attention to any mild, short-lived side effects.
Residents were encouraged to contact their nearest health centre for further inquiries or visit the National Primary Health Care Development Agency website for additional guidance.
